Salmonella vaccine materials and methods
US6923957B2 · kind B2 · utility
28Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2001 |
| Grant date | Aug 2, 2005 |
| Priority date | — |
| Expiry date | Oct 30, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/523
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Attenuated mutant Salmonella bacteria containing inactivated virulence genes are provided for use in safe, efficacious vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.